First National Bank of Omaha’s Gilead Sciences GILD Stock Holding History

First National Bank of Omaha’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,591	Closed	-$257K	–	388
2017 Q4	$257K	Buy	3,591 +1,035	+40%	+$78.6K	0.02%	373
2017 Q3	$207K	Sell	2,556 -312	-11%	-$23.9K	0.01%	377
2017 Q2	$203K	Sell	2,868 -450	-14%	-$29.9K	0.01%	384
2017 Q1	$226K	Sell	3,318 -49,002	-94%	-$3.45M	0.01%	390
2016 Q4	$3.75M	Sell	52,320 -1,439	-3%	-$107K	0.23%	133
2016 Q3	$4.25M	Sell	53,759 -30,992	-37%	-$2.52M	0.31%	110
2016 Q2	$7.07M	Sell	84,751 -9,070	-10%	-$805K	0.52%	69
2016 Q1	$8.62M	Sell	93,821 -2,699	-3%	-$243K	0.64%	45
2015 Q4	$9.77K	Sell	96,520 -935	-1%	-$97.3K	0.7%	37
2015 Q3	$9.57K	Buy	97,455 +12,647	+15%	+$1.4M	0.71%	36
2015 Q2	$8.52K	Hold	84,808	–	–	0.59%	52
2015 Q1	$8.52K	Buy	84,808 +773	+0.9%	+$78.5K	0.59%	52
2014 Q4	$7.92M	Buy	84,035 +4,787	+6%	+$495K	0.55%	56
2014 Q3	$8.44M	Buy	79,248 +1,085	+1%	+$106K	0.61%	42
2014 Q2	$6.48M	Buy	+78,163	New	+$6.08M	0.46%	73

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First National Bank of Omaha's GILD Position: Q1 2018 in Review

First National Bank of Omaha sold out of Gilead Sciences (GILD) in Q1 2018, closing a stake of 3,591 shares — an estimated $257K sold.

First National Bank of Omaha first reported a position in GILD in Q2 2014 and held it in 15 quarters. The position peaked at $8.62M in Q1 2016. 1,564 funds tracked by Wall St. Rank hold GILD as of Q1 2018.

First National Bank of Omaha reported no remaining Gilead Sciences position as of Q1 2018 after selling out during the quarter.
First National Bank of Omaha sold 3,591 Gilead Sciences shares in Q1 2018, an estimated $257K.
First National Bank of Omaha first reported a position in Gilead Sciences in Q2 2014 and held it in 15 quarters.
First National Bank of Omaha's Gilead Sciences position peaked at $8.62M in Q1 2016.
1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2018.

Based on First National Bank of Omaha's 13F filing for Q1 2018, filed 3 May 2018.